Merck & Co
Merck on Thursday said it earned $3.46 billion, or $1.61 per share, in the third quarter. That compared with $1.12 billion, or 51 cents per share, in the year-earlier period.
Excluding special items, Merck earned 90 cents per share. Analysts on average expected 82 cents per share, according to Thomson Reuters I/B/E/S.
Global company sales rose 2 percent to $6.05 billion, a bit higher than Wall Street's expectations of $6 billion.
To pave the way for its planned $41 billion purchase of Schering-Plough, Merck in July agreed to sell its half stake in the Merial pet care business for $4 billion to long-standing
partner Sanofi-Aventis SA
(Reporting by Ransdell Pierson, editing by Maureen Bavdek)